Novartis Ag (NVS) Research & Development (2009 - 2026)
Novartis Ag (NVS) reported Research & Development of -$2.85 billion for Q2 2026, compared with -$2.73 billion a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) Research & Development (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novartis Ag's Research & Development came in at -$11.69 billion; for FY2025, it came in at -$11.2 billion.
- By year, Research & Development came in at -$10.02 billion in FY2024, -$11.37 billion in FY2023, -$9.17 billion in FY2022 and -$8.64 billion in FY2021.
- Five-year quarterly Research & Development spans a low of -$3.93 billion in Q3 2023 and a high of -$2.22 billion in Q4 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$2.74 billion (Q1 2026), -$3.16 billion (Q4 2025) and -$2.94 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Vertex Pharmaceuticals | 130.00 Bn | 102.01 Bn | 2.84 Bn | 993.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.85 Bn |
| Mar 31, 2026 | -2.74 Bn |
| Dec 31, 2025 | -3.16 Bn |
| Sep 30, 2025 | -2.94 Bn |
| Jun 30, 2025 | 2.73 Bn |
| Mar 31, 2025 | -2.37 Bn |
| Dec 31, 2024 | -2.84 Bn |
| Sep 30, 2024 | -2.39 Bn |
| Jun 30, 2024 | 2.37 Bn |
| Mar 31, 2024 | -2.42 Bn |
| Dec 31, 2023 | -2.57 Bn |
| Sep 30, 2023 | -3.93 Bn |
| Jun 30, 2023 | 2.30 Bn |
| Mar 31, 2023 | -2.58 Bn |
| Dec 31, 2022 | -2.22 Bn |
| Sep 30, 2022 | -2.54 Bn |
| Jun 30, 2022 | 2.50 Bn |
| Mar 31, 2022 | -2.32 Bn |
| Dec 31, 2021 | -2.41 Bn |
| Sep 30, 2021 | -2.38 Bn |
API Access
Novartis Ag Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();